NEW YORK, Oct. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ: STSS) today announced a stock repurchase program to acquire up to $100 million of the company's outstanding common stock. This new stock repurchase program will enable the company to repurchase its shares in the open market and in negotiated transactions.
STSS previously announced its plans to establish a Solana digital asset treasury strategy and has acquired over 2 million SOL thus far.
Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this release other than statements of historical fact are forward-looking statements, including statements regarding the Company's execution of its Solana digital asset treasury strategy, and the potential opportunities such initiatives may create for retail and institutional audiences. Forward-looking statements are based on current expectations, assumptions, and beliefs, and involve risks and uncertainties that could cause actual results to differ materially.
This announcement contains forward-looking statements regarding Sharps Technology's stock buyback program. These statements reflect the company's current expectations and are subject to risks and uncertainties. The buyback program is intended to enhance shareholder value and demonstrates confidence in the company's long-term growth prospects. However, the timing, amount, and method of repurchasing shares will depend on market conditions, regulatory requirements, and other factors. There is no guarantee that the program will be completed as planned. These forward-looking statements are made in good faith and based on reasonable assumptions but are not guarantees of future performance.
These risks and uncertainties include, among others: the Company's ability to successfully execute its Solana treasury strategy; volatility in the market price of SOL and other digital assets; changes in the regulatory or legal environment; competitive pressures; and general market, economic, and business conditions. Additional risks are described in the "Risk Factors" section of the Company's filings with the Securities and Exchange Commission (the "SEC"), which are available on the SEC's website at www.sec.gov.
Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise these statements, whether as a result of new information, future developments, or otherwise, except as required by law.
About Sharps Technology
Sharps Technology is a medical device sales and distribution company that has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.
Contact
Prosek Partners for Sharps Technology
This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$2.46 |
| Daily Change: | -0.20 -7.52 |
| Daily Volume: | 790,929 |
| Market Cap: | US$69.450M |
November 17, 2025 September 16, 2025 September 10, 2025 August 28, 2025 June 18, 2025 | |

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load